SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Dewey Christopher C

(Last)

(First)

(Middle)

BOX 23

173 LAMINGTON ROAD

(Street)

OLDWICK

08858

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/14/2008

3. Issuer Name and Ticker or Trading Symbol
MAKO Surgical Corp. [ MAKO ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1,409,900	I	By Z-KAT, Inc.⁽¹⁾

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Series A Convertible Preferred Stock	12/17/2004	⁽²⁾	Common Stock	291,372⁽²⁾	⁽²⁾	D
Series A Convertible Preferred Stock	01/11/2008	⁽²⁾	Common Stock	3,300⁽²⁾⁽³⁾	⁽²⁾	I	By Daughter
Series A Convertible Preferred Stock	01/11/2008	⁽²⁾	Common Stock	3,300⁽²⁾⁽³⁾	⁽²⁾	I	By Daughter
Series A Convertible Preferred Stock	06/29/2005	⁽²⁾	Common Stock	22,984⁽²⁾	⁽²⁾	D
Series B Convertible Preferred Stock	07/14/2005	⁽²⁾	Common Stock	190,019⁽²⁾	⁽²⁾	D
Series C Convertible Preferred Stock	02/06/2007	⁽²⁾	Common Stock	214,302⁽²⁾	⁽²⁾	D
Common Stock Warrants (right to buy)	12/17/2004	12/17/2014	Common Stock	111,182	$3	D

Explanation of Responses:

1. The reporting person is a member of the board of directors of Z-KAT, Inc. and serves as the acting Chief Executive Officer of Z-KAT, Inc., but he disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

2. The convertible preferred stock has no expiration date. As a result of a one-for-3.03 reverse split of MAKO Surgical Corp. common stock, each share of convertible preferred stock is convertible into .330033 of a share of common stock. Accordingly, upon the closing of the issuer's initial public offering, the convertible preferred stock will convert into the number of shares of common stock set forth in Column 3.

3. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose.

Remarks:

Exhibit List Exhibit 24 - Power of Attorney

	/s/Menashe R. Frank, attorney in fact	02/14/2008
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.